Though genetic variations at the R1398 site have been shown to decrease the risk to develop PD (Ross et al., 2011; Heckman et al., 2014), the differential contribution of the two enzymatic activities of LRRK2 to the neurodegenerative processes during PD is not fully understood and might be rather complex. Here, LRRK2 is linked to Parkinson disease.